Vincenzo Alfano, Speaker at Vaccines Conferences
Keynote Presentation
Vincenzo Alfano, University of Messina, Italy

Attitude toward vaccination is doubtless an important determinant of public health, and this become evident during a pandemic. The issue, periodically debated within European societies since some years, especially with respect to occasional surge of diseases in given years and se [....] » Read More

Sudhakar Bangera, Speaker at Vaccines Conferences
Keynote Presentation
Sudhakar Bangera, University of Hong Kong, India

Biological therapeutics, also referred to as Biologicals, are those diverse group of medicines that are grown and then purified from large-scale cell cultures of bacteria or yeast, or plant or animal cells. Biologicals include a wide range of products such as vaccines, allergenic [....] » Read More

David Forgacs, Speaker at Vaccines Conferences
Oral Presentation
David Forgacs, University of Georgia Center for Vaccines and Immunology, United States

Since the COVID-19 pandemic started in late 2019, there have been over 400 million reported cases of SARS-CoV-2 infections, and since the start of the vaccine rollouts in December 2020, over 4 billion people have been fully vaccinated with a COVID-19 vaccine. In order to longitud [....] » Read More

Christine Bricault, Speaker at Vaccines Conferences
Oral Presentation
Christine Bricault, Sanofi Vaccines, United States

Human metapneumovirus (hMPV) is a major cause of acute respiratory tract infections in both infants and older adults. Currently there are no approved vaccines or antibody therapies for treatment against infection from hMPV. The key target of neutralizing antibodies is the viral f [....] » Read More

Rosane Cuber Guimaraes, Speaker at Vaccines Conferences
Oral Presentation
Rosane Cuber Guimaraes, Bio-Manguinhos/ Fiocruz, Brazil

Since the beginning of Sars-CoV-2 virus pandemic in Brazil on March 2020, Fiocruz has been part of various national and international fronts for the search and production of a vaccine against COVID-19. With a long history and a tradition of more than 70 years in vaccines producti [....] » Read More

Julia Bespyatykh, Speaker at Vaccine Conferences
Oral Presentation
Julia Bespyatykh, Federal Research and Clinical Centre of Physical-Chemical Medicine, Russian Federation

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread extremely quickly around the world, leading to medical and economic crises. Vaccination against SARS-CoV-2 infection is considered an effective preventive measu [....] » Read More

Tibyan A  Abdallah, Speaker at Vaccines Conferences
Oral Presentation
Tibyan A Abdallah, University of Khartoum, Sudan

Background: To combat the newly emerging pandemic (Corona virus disease 2019 (COVID-19)) different preventive measures are advised. World Health Organization recommended vaccination as an important intervention for ending this pandemic. This study aims to understand the willingne [....] » Read More

Kaleem Ullah, Speaker at Vaccines Conferences
Oral Presentation
Kaleem Ullah, Unicef, Pakistan

Vaccine hesitancy: we do have a lot of issues from the community which make them hesitant towards vaccination process, includes disinformation about the vaccination spread by the community instigators play important role in this regards apart from that we do have a lot of religio [....] » Read More

Nemat Khansari, Speaker at Vaccines Conferences
Oral Presentation
Nemat Khansari, Tehran University Medical Sciences, Iran (Islamic Republic of)

After the discovery of cowpox inoculation that can protect human from getting smallpox infection, vaccination became an important protective means for prevention measures for various infectious diseases. Although, vaccination was first applied to reduce mortality and morbidity fr [....] » Read More

Muhammad Naveed Anwar, Speaker at Speaker for Vaccine Conferences- Muhammad Naveed Anwar
Oral Presentation
Muhammad Naveed Anwar, Chinese Academy of Agricultural Sciences, Pakistan

Japanese encephalitis (JE) is a vector-borne zoonotic viral disease caused by (Japanese encephalitis virus, JEV). Vaccination is the most effective way to control JE in both humans and animals. However, JEV genotype shift that the dominant genotype III (GIII) has been replaced by [....] » Read More

Laleh Yazdanpanah Goharrizi, Speaker at 
Therapeutic Vaccines Conferences
Oral Presentation
Laleh Yazdanpanah Goharrizi, Agricultural Research Education and Extension Organization, Iran (Islamic Republic of)

Researchers are looking for pathogens of shrimp without pathogens or SPF and shrimp tolerant to viral agents that are not pathogenic to humans and can only be pathogenic to shrimp and crustaceans. In 1998, a scientist stated that shrimp and insects could retain viruses for long p [....] » Read More

Mina Ziarati, Speaker at COVID- 19 Vaccine Conferences
Oral Presentation
Mina Ziarati, Islamic Azad University, Iran (Islamic Republic of)

In contemporary world, Coronavirus disease (COVID-19) is concerned as a transmittable disease from bat to humans and a factor caused public health anxiety. Although, several measures were performed to treat it but still the mortality is seen in around the world. One of the most s [....] » Read More

Mohammad Jalil Zorriehzahra, Speaker at Speaker for Vaccine Conferences- Mohammad Jalil Zorriehzahra
Oral Presentation
Mohammad Jalil Zorriehzahra, Iranian Fisheries Science Research Institute, Greenland

Aquaculture currently has the highest growth in the world among different disciplines for the production of protein materials (15.7%). However, the occurrence of various infectious diseases (bacterial, viral, fungal and parasitic) among aquatic animals are a serious risk in this [....] » Read More

Angelo Tunin Chica Pergo, Speaker at Therapeutic Vaccines Conferences
Oral Presentation
Angelo Tunin Chica Pergo, Faculty Of Medicine Of Itajuba, Brazil

This is a psychometric study aimed at developing and validating a specific scale that assesses the vaccinal hesitancy (VH) behaviours of COVID-19 vaccines. Vaccine Hesitancy Scale for Covid-19 vaccines was developed in Brazil based on the Vaccine Hesitancy Scale (VHS), developed [....] » Read More

Ismail Hossain, Speaker at Vaccines Conferences
Poster Presentation
Ismail Hossain, Globe Biotech, Bangladesh

Antibiotic resistance is global trouble and in the megacities, it is causing more rapidly due to the misuse and overuse of antibiotics. This systematic evaluation used to be carried out to summarize the contemporary day kingdom of affairs of antibiotic resistance in Dhaka, to eme [....] » Read More

Sherif Salah , Speaker at Vaccines Conferences
Poster Presentation
Sherif Salah , Cairo University , Egypt

A novel mode of action for HIV assumes that production of neutralizing anti-HIV antibodies is the main cause in enhancing the viral infection and its protections against destructors by the cytotoxic CD8+ T-cells. Depends on this novel postulation a new formulation treatment terme [....] » Read More

Zahra Mohammed A Alhajjaj , Speaker at Vaccines Conferences
Poster Presentation
Zahra Mohammed A Alhajjaj , Collage of Medicine,Hail University , Saudi Arabia

Introduction: Coronavirus (COVID-19) a new member of the human coronavirus’s family, was identified in 2019 as the causative agent of a new disease outbreak in China associated with severe medical complications and even death in some cases. The unavailability of a vaccine o [....] » Read More

Mohammad Owais, Speaker at Immunology Conferences
Oral Presentation
Mohammad Owais, Aligarh Muslim University, India

The scourge of tuberculosis is continuing to toll around 1.5 million human lives annually. The only vaccine against tuberculosis is BCG which gives varied protection in various regions and races of the world. Developing new vaccine based on mycobacterial strains is a challenging [....] » Read More